Latest Moderna News & Updates

See the latest news and media coverage for Moderna. We track all announcements, press releases, and industry mentions in real time, all in one place.

Moderna

Developer of mRNA therapeutics and vaccines

Last updated Today

Latest news about Moderna

In short: Moderna reported positive Phase 3 melanoma data, received FDA panel backing for its flu vaccine, and secured $2.6 billion in funding.

August 19 Moderna

Intismeran autogene plus pembrolizumab improves outcomes in Stage IIB-IV melanoma versus standard-of-care alone.

August 6 Moderna

The vaccine is approved for adults 50 years and older, following unanimous support from the FDA's advisory committee.

July 31 Moderna

CEO Stéphane Bancel, President Stephen Hoge, and CFO Jamey Mock discussed performance, cost discipline, and late-stage pipeline milestones.

June 25 Moderna

CEO Stéphane Bancel details plans for near-term growth, new modalities, and AI-driven innovation to achieve cash breakeven by 2028.

September 8 Webpronews

Rothschild analyst Simon Baker downgrades Moderna stock to Sell from Neutral while doubling his...

Never miss news about Moderna

Track Moderna and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Browse news for competitors to Moderna and other trending companies.